Anti-tumor Activity of Dendritic Cells Loading in Situ Tumor Lysate Antigen Proudced by Radiofrequency Ablation
Shan Chanchan,Shi Liangrong,Zhu Yibei,Xu Bin,Ding Meiqian,Jiang Jingting,Wu Changping
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2014.08.046
2014-01-01
Abstract:Objective To evaluate the anti-tumor activity of dendritic cells (DCs) loading in situ tumor lysate antigen proudced by radiofrequency ablation (RFA).Methods DCs derived from bone marrow were prepared,and experimental model of murine colon carcinoma was established for RFA.The supernatant of tumor tissue in situ lysis after repeated freezing and thawing was tested by Lowry protein quantitative statutory,amount to a final concentration of 5 mg/L,then load to the first 5 days of culture DCs (Ag-DCs),using flow cytometry analysis the differences of the surface molecules [CD11 c,major histocompatibility complex (MHC)-Ⅱ,CD80,CD86] between Ag-DCs and DCs.Three groups of cancer treatment and prevention models were established respectively:Ag-DC group,DC group and PBS control group.Using ANOVA analysis of variance comparing three groups implanted tumor volume trends,Log-rank test to compare three groups of mice survival time.Results The surface of Ag-DCs expressed CD80,CD86,MHC-Ⅱ,CD11c,respectively,86.3％,29.4％,75.4％,82.5％ ; untreated DCs expressed costimulatory molecules CD80,CD86,MHC-Ⅱ,CD11c respectively,68.6％,15.1％,64.5％,66.7％.The cancer prevention model of mice tips seven days tumor grow probabilities:Ag-DC group 60％ (3/5),DC group 80％ (4/5),PBS control group 100％ (5/5) ; and Ag-DC mice showed slow-growing tumor volume compared with PBS and DC groups immunized mice,the difference was statistically significant (P ＜ 0.01).Treatment model suggested:the average survival time of Ag-DC group was (39 ± 8) d,DC group was (28 ± 4) d,PBS group was (22 ± 3) d,the difference was statistically significant (P ＜ 0.01) ; and the growth of tumor volume of Ag-DC group was slow,compared with PBS and DC groups,the difference was statistically significant (P ＜ 0.01).Conclusion Radiofrequency ablation in situ tumor lysate as an antigen can effectively stimulate DCs to produce specific anti-tumor immune response,suggesting that the antigen loading DCs as an anti-tunor immunotherapy strategie are suitable for clinical application.